PHASE-II CLINICAL-STUDY OF HIGH-DOSE TOREMIFENE IN PATIENTS WITH ADVANCED BREAST-CANCER

被引：8

作者：

MODIG, H

BORGSTROM, S

NILSSON, I

WESTMAN, G

机构：

[1] MALMO GEN HOSP,DEPT ONCOL,S-21401 MALMO,SWEDEN

[2] OREBRO REG HOSP,DEPT ONCOL,OREBRO,SWEDEN

来源：

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 1990年 / 36卷 / 03期

关键词：

D O I：

10.1016/0022-4731(90)90015-K

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Thirteen postmenopausal women with advanced local or metastatic breast cancer were treated with the antiestrogen toremifene at a daily dose of 200 mg. All patients had failed previous treatment with different types of endocrine therapy and/or cytotoxic drugs. Objective response was only seen in one patient. Treatment was usually well tolerated but in three cases the drug had to be withdrawn due to side effects. © 1990.

引用

页码：237 / 238

页数：2